{"protocolSection": {"identificationModule": {"nctId": "NCT00770679", "orgStudyIdInfo": {"id": "NA00002253"}, "organization": {"fullName": "Johns Hopkins University", "class": "OTHER"}, "briefTitle": "Effects of Statins on Lower Extremity Arterial Function Assessed by Magnetic Resonance Imaging", "officialTitle": "Effects of Statins on Lower Extremity Arterial Function Assessed by Magnetic Resonance Imaging"}, "statusModule": {"statusVerifiedDate": "2017-08", "overallStatus": "TERMINATED", "whyStopped": "Delayed recruitment, funding exhausted", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2008-06", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2012-07", "type": "ACTUAL"}, "completionDateStruct": {"date": "2012-07", "type": "ACTUAL"}, "studyFirstSubmitDate": "2008-10-09", "studyFirstSubmitQcDate": "2008-10-09", "studyFirstPostDateStruct": {"date": "2008-10-10", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2017-07-17", "resultsFirstSubmitQcDate": "2017-08-14", "resultsFirstPostDateStruct": {"date": "2017-09-13", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2017-08-14", "lastUpdatePostDateStruct": {"date": "2017-09-13", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Johns Hopkins University", "class": "OTHER"}, "collaborators": [{"name": "Pfizer", "class": "INDUSTRY"}]}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "Cholesterol-lowering drugs called statins improve the functioning of the endothelium, and help prevent heart disease. The investigators are testing whether statins improve endothelial function more in the arteries that have worse endothelium to begin with. One of the functions of the endothelium is to help control how blood vessels dilate (expand) or contract (narrow) in different situations. This affects how blood flows through those vessels. Magnetic resonance imaging (MRI) can be used to evaluate endothelial function in the arms and legs noninvasively.", "detailedDescription": "Correct"}, "conditionsModule": {"conditions": ["Diabetes"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "NA", "interventionModel": "SINGLE_GROUP", "primaryPurpose": "DIAGNOSTIC", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 16, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "High-Dose Statin", "type": "EXPERIMENTAL", "description": "80 mg atorvastatin daily for 3 weeks", "interventionNames": ["Drug: lipitor"]}], "interventions": [{"type": "DRUG", "name": "lipitor", "description": "80 mg everyday (QD) for 3 weeks", "armGroupLabels": ["High-Dose Statin"], "otherNames": ["atorvastatin"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Mean Change in Low Density Lipoprotein (LDL)", "description": "Serum LDL, mg/dL (baseline LDL-follow-up LDL)", "timeFrame": "Change from baseline to follow-up, up to 5 weeks"}, {"measure": "Change in Endothelial Function as Measured on MRI in the Arms", "timeFrame": "chance from baseline to end of study, up to 5 weeks"}, {"measure": "Change in Endothelial Function as Measured on MRI in the Legs", "timeFrame": "chance from baseline to end of study, up to 5 weeks"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Age 40-90\n* Male or female\n* Type 2 diabetes\n\nExclusion Criteria:\n\n* Known pregnancy or nursing.\n* Females of child bearing potential must have been surgically sterilized or be post menopausal.\n* Smoking\n* Known vascular disease\n* Inability to complete MRI scan\n* Symptoms of claudication\n* Use of a nitrate medicine\n* Use of any cholesterol-lowering agent\n* LDL \\< 70\n* Acute illness\n* Liver disease\n* Contraindication to getting an MRI scan (i.e. electronic implant, shrapnel, cerebral aneurysm clip, welding history).", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "40 Years", "maximumAge": "90 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Harry Silber, MD", "affiliation": "JHU", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Harry SIlber, MD", "city": "Baltimore", "state": "Maryland", "zip": "21224", "country": "United States", "geoPoint": {"lat": 39.29038, "lon": -76.61219}}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "High-Dose Statin", "description": "80 mg atorvastatin daily for 3 weeks\n\nlipitor: 80 mg everyday (QD) for 3 weeks"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "16"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "10"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "6"}]}], "dropWithdraws": [{"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "3"}]}, {"type": "Follow-up LDL measurement not collected", "reasons": [{"groupId": "FG000", "numSubjects": "3"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "High-Dose Statin", "description": "80 mg atorvastatin daily for 3 weeks\n\nlipitor: 80 mg everyday (QD) for 3 weeks"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "16"}]}], "measures": [{"title": "Age, Customized", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": ">=40, <=90, years", "categories": [{"measurements": [{"groupId": "BG000", "value": "16"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "6"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "10"}]}]}]}, {"title": "Region of Enrollment", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "16"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Mean Change in Low Density Lipoprotein (LDL)", "description": "Serum LDL, mg/dL (baseline LDL-follow-up LDL)", "populationDescription": "3 participants were lost to follow-up, 3 participants did not have LDL values collected/reported at follow-up", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg/dL", "timeFrame": "Change from baseline to follow-up, up to 5 weeks", "groups": [{"id": "OG000", "title": "High-Dose Statin", "description": "80 mg atorvastatin daily for 3 weeks\n\nlipitor: 80 mg everyday (QD) for 3 weeks"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "10"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "75.54", "spread": "12.98"}]}]}]}, {"type": "PRIMARY", "title": "Change in Endothelial Function as Measured on MRI in the Arms", "populationDescription": "No data was collected for this outcome measure. The outcome was not able to be calculated based upon data obtained and programs and investigator capabilities.", "reportingStatus": "POSTED", "timeFrame": "chance from baseline to end of study, up to 5 weeks", "groups": [{"id": "OG000", "title": "High-Dose Statin", "description": "80 mg atorvastatin daily for 3 weeks\n\nlipitor: 80 mg everyday (QD) for 3 weeks"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}]}]}, {"type": "PRIMARY", "title": "Change in Endothelial Function as Measured on MRI in the Legs", "populationDescription": "No data was collected for this outcome measure. The outcome was not able to be calculated based upon data obtained and programs and investigator capabilities.", "reportingStatus": "POSTED", "timeFrame": "chance from baseline to end of study, up to 5 weeks", "groups": [{"id": "OG000", "title": "High-Dose Statin", "description": "80 mg atorvastatin daily for 3 weeks\n\nlipitor: 80 mg everyday (QD) for 3 weeks"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "eventGroups": [{"id": "EG000", "title": "High-Dose Statin", "description": "80 mg atorvastatin daily for 3 weeks\n\nlipitor: 80 mg everyday (QD) for 3 weeks", "deathsNumAffected": 0, "deathsNumAtRisk": 16, "seriousNumAffected": 0, "seriousNumAtRisk": 16, "otherNumAffected": 0, "otherNumAtRisk": 16}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": true}, "pointOfContact": {"title": "Harry Silber, M.D., Ph.D. Assistant Professor of Medicine, Division of Cardiology", "organization": "Johns Hopkins University School of Medicine", "email": "hsilber@jhmi.edu", "phone": "4105505717"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"browseLeaves": [{"id": "M7115", "name": "Diabetes Mellitus", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC18", "name": "Nutritional and Metabolic Diseases"}, {"abbrev": "BC19", "name": "Gland and Hormone Related Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000069059", "term": "Atorvastatin"}], "ancestors": [{"id": "D000000924", "term": "Anticholesteremic Agents"}, {"id": "D000000960", "term": "Hypolipidemic Agents"}, {"id": "D000000963", "term": "Antimetabolites"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}, {"id": "D000057847", "term": "Lipid Regulating Agents"}, {"id": "D000019161", "term": "Hydroxymethylglutaryl-CoA Reductase Inhibitors"}, {"id": "D000004791", "term": "Enzyme Inhibitors"}], "browseLeaves": [{"id": "M351", "name": "Atorvastatin", "asFound": "General", "relevance": "HIGH"}, {"id": "M21155", "name": "Hydroxymethylglutaryl-CoA Reductase Inhibitors", "relevance": "LOW"}, {"id": "M4243", "name": "Anticholesteremic Agents", "relevance": "LOW"}, {"id": "M4278", "name": "Hypolipidemic Agents", "relevance": "LOW"}, {"id": "M4281", "name": "Antimetabolites", "relevance": "LOW"}, {"id": "M28883", "name": "Lipid Regulating Agents", "relevance": "LOW"}, {"id": "M7951", "name": "Enzyme Inhibitors", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Lipd", "name": "Lipid Regulating Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}